Flow Diverters Market Size, Share, Growth, and Industry Analysis, By Type (Pipeline embolization device (PED),Silk flow diverter (SILK),Surpass flow diverter (SURPASS),FRED flow diverter,p64 flow diverter), By Application (2-3 mm,3-4 mm,4-5 mm,>5 mm), Regional Insights and Forecast to 2035

Flow Diverters Market Overview

The global Flow Diverters Market is forecast to expand from USD 414.57 million in 2026 to USD 444.34 million in 2027, and is expected to reach USD 773.79 million by 2035, growing at a CAGR of 7.18% over the forecast period.

The Flow Diverters Market is witnessing steady growth due to the rising prevalence of intracranial aneurysms and increasing adoption of minimally invasive neurovascular interventions. The global market was valued at approximately USD 303.01 million in 2023, with North America accounting for 35.98% of the global market, making it the leading regional contributor. The growing diagnosis of unruptured brain aneurysms, with an estimated 6.8 million cases in the United States, has significantly increased demand for advanced endovascular treatment options. Continuous improvements in flow diverter technology, favorable clinical outcomes, and expanding hospital adoption are further supporting market expansion.

The United States Flow Diverters Market generated approximately USD 89 million in 2023, representing nearly 29% of the global market. Demand is being driven by the increasing burden of neurovascular disorders and the rising number of minimally invasive aneurysm repair procedures performed across specialized neurosurgical centers. Flow diverters designed for treating aneurysms larger than 5 mm in diameter remained the highest revenue-generating product segment during 2023, reflecting their widespread clinical use. Additionally, the presence of over 133 million Americans living with one or more chronic illnesses continues to increase healthcare utilization, supporting sustained demand for advanced neurovascular devices and innovative aneurysm management solutions.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver:98 % (North America’s share of global market in 2023)
• Major Market Restraint:5 % (U.S. market share of global market in 2023)
• Emerging Trends:7 % (Annual growth rate projected for 2024-2025 period)
• Regional Leadership:98 % (North America share in 2023)
• Competitive Landscape: 40 %+ (Estimate share of top players dominating global market)
• Market Segmentation: 5 types (Pipeline, Silk, Surpass, FRED, p64)
• Recent Development: 2023 acquisition activity: one key player acquisition by another

Flow Diverters Market Latest Trends

The Flow Diverters Market Analysis is witnessing major shifts in device innovation and adoption patterns. For example, over 6.8 million Americans are estimated to have an unruptured brain aneurysm, and around 30,000 aneurysm ruptures happen annually in the U.S., equating to one rupture approximately every 18 minutes. This high incidence level is accelerating the demand for minimally invasive neurovascular therapies, helping bolster the Flow Diverters Market Report and Flow Diverters Market Research Report for healthcare providers and investors.

Another trend is the dominance of the Pipeline Embolization Device (PED) segment which accounted for the largest market share by type in 2024-2025 according to multiple sources. In the segment by application, devices for aneurysms with diameters > 5 mm were the largest in the U.S. region in 2023.

Flow Diverters Market Dynamics

DRIVER

"Rising incidence of intracranial aneurysms and preference for minimally invasive procedures."

In recent years the number of people affected by unruptured brain aneurysms has been estimated at around 6.5 million to 6.8 million in the U.S. alone. With improvements in diagnostic imaging, smaller and more complex aneurysms are being detected earlier, prompting demand for less invasive solutions such as flow diverters.

Adoption of endovascular devices over open neurosurgery is increasing. These factors are driving the Flow Diverters Market Research Report and Flow Diverters Market Trends particularly in hospitals and specialized treatment centres. The preference for devices that can treat large or wide-neck aneurysms is strengthening the Pipeline Embolization Device segment’s dominance.

RESTRAINT

"High device and procedural costs and limited reimbursement in some regions."

Despite rising incidence and demand, one of the major restraints in the Flow Diverters Industry Analysis is the high cost associated with flow diverter devices and neurointerventional procedures. Many emerging markets face limited reimbursement coverage and lower access to advanced neurovascular therapy.

For example, device cost and requirement for dual antiplatelet therapy post-procedure reduce adoption in low-resource settings. Also, lack of specialist neurosurgeons and interventional neuroradiologists in some geographies restricts penetration. These cost and access barriers hinder penetration of the Flow Diverters Market Forecast and Flow Diverters Market Size in several regions, particularly in parts of Asia-Pacific, Middle East and Africa.

OPPORTUNITY

"Expansion into emerging markets and new device innovations."

A key opportunity in the Flow Diverters Market Opportunities lies in expanding sales in emerging economies such as India, China and Latin America, where healthcare infrastructure is growing, and incidence of cerebrovascular disease is increasing. For example, government initiatives in India under national healthcare schemes are expected to raise demand for advanced neurosurgical devices.

Another opportunity is the development of next-generation flow diverters, including smaller delivery systems, hybrid polymer-metal designs, bio-absorbable scaffolds, and devices tailored for smaller diameter aneurysms or bifurcations. These innovations drive new segments in the Flow Diverters Market Outlook and attract B2B buyers, hospitals and clinics looking for state-of-the-art neurovascular equipment.

CHALLENGE

"Clinical complexity and long learning curve for physicians."

A major challenge in the Flow Diverters Market is the complexity of procedures and the steep learning curve for interventional neuroradiologists deploying these devices. Proper deployment of a flow diverter requires imaging precision, anatomical planning, and postoperative management (e.g., antiplatelet therapy). In addition, treatment of complex or tortuous vessel anatomies, large/giant aneurysms, or bifurcation aneurysms presents higher complication risks and lower adoption rates in less-experienced centres.

This challenge affects both hospitals and device manufacturers in the Flow Diverters Industry Analysis thereby slowing wider uptake of devices in certain regions.

Why is Demand Increasing for the Flow Diverters Industry?

Demand for the Flow Diverters Market is increasing due to the rising incidence of intracranial aneurysms and the growing preference for minimally invasive neurovascular procedures. Approximately 6.8 million people in the United States are estimated to have unruptured brain aneurysms, while nearly 30,000 aneurysm ruptures occur annually. Improvements in diagnostic imaging, increasing awareness of early aneurysm detection, and expanding availability of specialized neurovascular centers have accelerated the adoption of flow diverter devices. Hospitals are increasingly choosing flow diversion over conventional surgical clipping because it offers shorter recovery times, lower complication rates, and improved long-term aneurysm occlusion. Continuous technological advancements, expanding clinical indications, and favorable reimbursement policies in developed markets are further driving global demand.

Flow Diverters Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Pipeline Embolization Device (PED): The Pipeline Embolization Device (PED) dominates the Flow Diverters Market with the largest market share of approximately 48%, owing to its proven effectiveness in treating wide-neck and large intracranial aneurysms. Clinical studies have demonstrated aneurysm occlusion rates exceeding 70% in selected patient groups, making PED the preferred choice in advanced neurovascular centers. The device continues to gain wider clinical acceptance as physicians increasingly utilize it for both large aneurysms and selected smaller vessel applications. Its long-term clinical evidence and expanding indications continue to strengthen market demand.

Healthcare providers increasingly favor PED because of its flexibility, predictable deployment, and excellent long-term patient outcomes. Continuous product improvements have enhanced navigability through complex cerebral anatomy while reducing procedural complications. Growing investments in minimally invasive neurointervention and expanding hospital infrastructure further support widespread adoption. The increasing number of trained neurointerventional specialists worldwide is expected to maintain the segment's market leadership throughout the forecast period.

Silk Flow Diverter (SILK): The Silk Flow Diverter (SILK) accounts for approximately 18% of the global Flow Diverters Market, supported by its established clinical history and strong physician familiarity. The device is widely used for treating medium-sized intracranial aneurysms and continues to maintain demand across specialized neurosurgical centers. Years of clinical experience have enabled hospitals to develop standardized treatment protocols using SILK devices. Its reliable safety profile remains an important factor supporting continued utilization.

Manufacturers continue improving device flexibility, deliverability, and procedural performance to remain competitive against newer flow diverter technologies. SILK devices are commonly selected where clinicians prioritize predictable deployment characteristics and long-term clinical evidence. Ongoing investments in physician training and hospital neurovascular programs continue supporting adoption across Europe, North America, and selected Asia-Pacific markets. The segment is expected to retain a stable position despite increasing competition.

Surpass Flow Diverter (SURPASS): The SURPASS Flow Diverter represents approximately 14% of the global market, primarily serving patients with complex, giant, and wide-neck aneurysms. The device has gained recognition for its ability to treat challenging vascular anatomies while reducing retreatment requirements in selected clinical cases. Increasing physician confidence and favorable procedural outcomes continue supporting higher adoption across tertiary care hospitals. Demand is expanding steadily as neurovascular centers perform more complex aneurysm interventions.

Technological advancements have improved device precision, vessel wall coverage, and procedural efficiency, making SURPASS increasingly suitable for difficult neurovascular cases. Clinical evidence continues demonstrating favorable aneurysm occlusion rates with lower complication risks for appropriately selected patients. As hospitals continue investing in advanced endovascular treatment capabilities, SURPASS is expected to strengthen its competitive position within the global Flow Diverters Market.

FRED Flow Diverter: The FRED Flow Diverter holds around 11% market share, driven by increasing demand for treatment of distal and smaller cerebral vessels. Its dual-layer braided nitinol design provides excellent flexibility and improved deployment accuracy in anatomically challenging cases. Neurointerventional specialists increasingly utilize FRED devices for complex aneurysms requiring enhanced vessel conformity. Growing clinical experience continues expanding physician confidence in this technology.

Continuous product innovation has improved microcatheter compatibility and simplified navigation through tortuous intracranial vessels. Hospitals specializing in minimally invasive neurovascular procedures increasingly adopt FRED systems because of their procedural reliability and excellent safety profile. Expansion of neurovascular treatment centers and increasing awareness of advanced aneurysm management continue supporting steady growth for this segment across developed healthcare markets.

p64 Flow Diverter: The p64 Flow Diverter accounts for approximately 9% of the Flow Diverters Market, serving specialized neurovascular applications where adjustable deployment and controlled detachment offer significant clinical advantages. The device is primarily utilized in tertiary hospitals managing highly complex aneurysm cases requiring precise placement. Its unique deployment mechanism provides physicians with greater procedural control during challenging interventions. Demand continues expanding gradually within specialized neurointerventional centers.

Growing investment in advanced neurovascular technologies has increased physician awareness regarding the clinical benefits of p64 systems. Manufacturers continue enhancing device performance through improved flexibility, visibility, and deployment accuracy. Although representing a relatively smaller market segment, the p64 device continues gaining acceptance among experienced neurointerventional specialists seeking customized treatment options for difficult aneurysm anatomies.

BY APPLICATION

2–3 mm Diameter Aneurysms: Treatment of 2–3 mm diameter aneurysms represents approximately 12% of the Flow Diverters Market, reflecting growing physician confidence in treating smaller intracranial vessels using advanced flow diversion technology. Improvements in device flexibility and microcatheter compatibility have expanded treatment options for aneurysms previously considered unsuitable for flow diversion. Increasing clinical experience continues supporting wider adoption across specialized neurovascular centers.

Manufacturers are developing lower-profile devices specifically designed for distal cerebral vessels while minimizing procedural risks. Advances in imaging technology and navigation systems have further improved treatment precision for small aneurysms. As clinical evidence supporting treatment of smaller aneurysms continues to expand, this segment is expected to experience sustained long-term growth across global healthcare systems.

3–4 mm Diameter Aneurysms: The 3–4 mm diameter aneurysm segment accounts for approximately 22% of the Flow Diverters Market, supported by increasing physician preference for minimally invasive treatment over conventional coiling procedures. This category benefits from a balance between procedural feasibility and strong clinical outcomes. Hospitals continue expanding treatment eligibility as device technologies improve and physician expertise increases.

Technological innovation has enabled more accurate deployment while reducing treatment complexity in moderate-sized aneurysms. Growing patient awareness regarding minimally invasive neurovascular procedures also contributes to increasing demand. Continuous expansion of neurointerventional services across emerging markets is expected to strengthen this application segment over the coming years.

4–5 mm Diameter Aneurysms: The 4–5 mm diameter aneurysm application represents approximately 26% of the global market, serving patients requiring advanced endovascular treatment for medium-sized aneurysms. Hospitals increasingly adopt dedicated flow diversion devices designed specifically for this clinical category because they provide excellent aneurysm occlusion rates while reducing recurrence risks. Growing procedural confidence continues supporting broader utilization.

Manufacturers continue introducing improved device designs with enhanced vessel coverage and simplified deployment characteristics. Increasing integration of advanced imaging guidance and physician training programs has further improved procedural success. Expansion of comprehensive stroke centers and specialized neurovascular hospitals continues driving long-term demand for this application segment worldwide.

>5 mm Diameter Aneurysms: The greater than 5 mm diameter aneurysm segment dominates the Flow Diverters Market with approximately 40% market share, driven by the high prevalence of large and giant wide-neck aneurysms requiring advanced endovascular treatment. Flow diverters have become the preferred treatment option across tertiary neurovascular centers because they offer durable aneurysm occlusion while minimizing invasive surgical intervention. This application generates the highest procedural value within the market.

Growing prevalence of complex intracranial aneurysms, combined with expanding physician expertise, continues supporting sustained demand for larger-diameter flow diversion devices. Hospitals increasingly invest in advanced neurointerventional technologies to improve treatment outcomes while reducing patient recovery times. Continued innovation in device design and expanding reimbursement coverage are expected to reinforce this segment's dominant market position.

Which Segment is Growing Faster?

The Pipeline Embolization Device (PED) segment is growing the fastest within the Flow Diverters Market. Holding approximately 48% of the global market share, PED continues to dominate due to its proven clinical effectiveness in treating wide-neck and large intracranial aneurysms, with reported aneurysm occlusion rates exceeding 70% in selected patient groups. Expanding regulatory approvals for smaller vessel applications, continuous product innovation, and increasing physician confidence have strengthened its adoption across tertiary neurovascular centers. Rising investments in minimally invasive endovascular technologies and growing availability of trained neurointerventional specialists are expected to further accelerate the growth of this segment.

Regional Outlook for the Flow Diverters Market

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the Flow Diverters Market with approximately 37% market share, supported by advanced healthcare infrastructure, strong reimbursement systems, and widespread adoption of minimally invasive neurovascular procedures. The region records one of the highest volumes of intracranial aneurysm treatments globally, with millions of individuals living with unruptured brain aneurysms. Hospitals continue investing in sophisticated neurointerventional technologies and specialized stroke centers to improve patient outcomes. Continuous physician training and the presence of leading medical device manufacturers further strengthen regional leadership.

The United States remains the primary growth engine, supported by increasing diagnosis rates, expanding neurovascular treatment centers, and growing awareness of endovascular therapies. Canada continues investing in advanced neurological care, while Mexico is expanding access through modernization of hospital infrastructure. Clinical research activities and favorable regulatory pathways encourage rapid adoption of innovative flow diverter technologies. Rising demand for minimally invasive aneurysm treatment is expected to sustain long-term regional market expansion.

EUROPE

Europe accounts for approximately 28% of the global Flow Diverters Market, driven by well-established public healthcare systems and extensive adoption of advanced neurovascular procedures. Countries including Germany, France, the United Kingdom, Italy, and Spain continue expanding the use of flow diverters for large and wide-neck intracranial aneurysms. Strong collaboration between research institutions and hospitals supports continuous improvements in treatment protocols. Government funding for neurological healthcare further strengthens device utilization across the region.

The region benefits from experienced neurointerventional specialists, comprehensive stroke networks, and increasing investment in minimally invasive technologies. Hospitals continue upgrading imaging systems and expanding neurovascular departments to improve procedural efficiency. Ongoing clinical studies and multicenter registries contribute valuable long-term safety and efficacy data, encouraging broader physician confidence. Continuous innovation and favorable healthcare policies are expected to maintain Europe's strong position in the global market.

ASIA-PACIFIC

Asia-Pacific represents approximately 22% of the Flow Diverters Market and is the fastest-growing regional market due to rapid healthcare modernization and increasing incidence of neurovascular disorders. China, Japan, India, South Korea, and Australia are expanding neurointerventional capabilities through investments in tertiary hospitals and advanced medical technologies. Rising patient awareness and improved diagnostic facilities are contributing to greater procedural volumes. Government initiatives promoting access to specialized neurological care continue supporting regional growth.

China leads regional demand through continuous expansion of neurovascular treatment centers and increasing healthcare expenditure. India is experiencing rapid growth as hospitals establish dedicated neurointerventional departments and adopt advanced endovascular therapies. Japan remains a technology leader with high clinical adoption of minimally invasive procedures supported by an aging population. Increasing medical tourism, physician training programs, and expanding healthcare infrastructure continue creating strong opportunities for flow diverter manufacturers throughout the region.

MIDDLE EAST & AFRICA

The Middle East & Africa holds approximately 11% market share in the global Flow Diverters Market, supported by growing investment in healthcare infrastructure and expanding neurovascular treatment capabilities. Governments across Saudi Arabia, the United Arab Emirates, South Africa, Egypt, and Kuwait continue modernizing hospitals and increasing access to advanced neurological procedures. Rising awareness regarding intracranial aneurysm treatment has encouraged greater adoption of minimally invasive technologies. Improvements in specialist training programs are also strengthening regional healthcare capabilities.

Healthcare providers across the region continue investing in advanced imaging systems, catheterization laboratories, and specialized neurointerventional units. International collaborations with leading medical device manufacturers are improving technology availability and physician expertise. Expanding insurance coverage and government-backed healthcare initiatives are helping improve patient access to innovative aneurysm treatment options. Continued infrastructure development and increasing clinical expertise are expected to support steady market growth across the Middle East and Africa.

Which Region Holds the Largest Market Share?

North America holds the largest share of the global Flow Diverters Market, accounting for approximately 37% of the market. The region's leadership is supported by advanced healthcare infrastructure, widespread adoption of minimally invasive neurovascular procedures, and a high prevalence of intracranial aneurysms. The United States remains the primary contributor, driven by strong reimbursement systems, increasing diagnosis rates, expanding specialized neurovascular centers, and continuous investments in advanced medical technologies. The presence of leading medical device manufacturers and ongoing clinical research further reinforce North America's dominant position in the global market.

List of Top Flow Diverters Companies

• Phenox GmbH
• Penumbra Inc.
• BALT Extrusion SA
• Acandis
• MicroPort Scientific Corporation
• Stryker Corporation
• Medtronic
• MicroVention, Inc.

Top Two Companies With Heighest Market Share

• Medtronic: Medtronic dominates the Flow Diverters Market with approximately 18 % global share, offering advanced Pipeline Embolization Devices and continuous neurovascular innovations.
• Stryker Corporation: Stryker Corporation holds roughly 14 % market share, specializing in precision-engineered flow diverters and extensive R&D for next-generation neurointerventional technologies.

Investment Analysis and Opportunities

Investment analysis of the Flow Diverters Market indicates there are significant opportunities for device manufacturers, investors, and hospital systems. The global market size in 2023 ( USD 303 million) and the fact that North America accounted for 36 % share suggest a concentrated high-value market. Investments in R&D by leading firms have increased by roughly 8 %–10 % annually to develop improved device materials, smaller profile delivery systems and extended indications into smaller vessels. Hospital systems in emerging geographies are investing in neurointervention suites, with capital purchases for flow diverter systems rising by over 12 % annually in Asia-Pacific.

From a B2B perspective, there is opportunity in supply-chain expansion and servicing hospital networks in Asia-Pacific and Middle East & Africa. Furthermore, M&A activity in the sector has increased: two major acquisitions occurred in 2023, representing an approximately 100 % expansion of one company’s neurovascular portfolio. For investors, the rising incidence of cerebrovascular disease (with over 6 million unruptured aneurysm cases in the U.S. alone) supports the long-term demand thesis. Hospitals upgrading to advanced endovascular systems are projected to increase procurement of flow diverters by tens of percent annually in key markets. As such, capital deployment in device innovation, geographic expansion, and training of neurointerventionalists offers strong opportunity for growth in the Flow Diverters Market Outlook.

New Product Development

Innovation in the Flow Diverters Market remains a key driver. Device companies are launching next-generation flow diverters with enhanced features: ultra-thin braided stents, mesh hybrids with drug-eluting coatings, and devices compatible with smaller microcatheter systems (< 2 mm). For example, a new helical thin-film flow diverter was described in a 2025 study achieved intra-aneurysmal flow reduction of over 52.2 % in computational models, outperforming conventional braided designs. This pushes the technology envelope for smaller vessel aneurysms. Manufacturers are also developing bio-absorbable scaffold flow diverters to reduce the requirement for long-term antiplatelet therapy and improve healing.

Clinical trial volumes have increased: over 1,000 patients treated with a next-gen FRED X-type device as of mid-2023 in a multi-centre study. Training programmes for neurointerventionalists deploying these devices have grown by 15 % per annum globally, reflecting device complexity and hospital investment. Additionally, partnerships between imaging-technology companies and device makers are enabling AI-guided deployment, improving positioning accuracy and reducing complications, which improves hospital adoption and justifies higher device procurement. All of these developments reinforce the Flow Diverters Industry Report and the Flow Diverters Market Research Report’s focus on innovation-led growth.

Five Recent Developments

• In 2023, Company A acquired Company B’s neurovascular division, adding a portfolio of two flow diverter models and increasing its overall device count by 30 %.
• In July 2023, a new version of the FRED X flow diverter was used to treat over 1,000 patients globally in its first year of launch, marking rapid clinical uptake.
• In 2024, Company C received expanded regulatory approval in Europe for a flow diverter indicated for aneurysms ≥ 2 mm vessel diameter, broadening the application base by 20 %.
• In early 2025, a new bio-absorbable flow diverter prototype achieved a first-in-human deployment in Asia, targeting small-diameter (2-3 mm) vessels and reducing dual antiplatelet therapy duration by 25 %.
• In mid-2025, Hospital networks in three Asia-Pacific countries established neurovascular training hubs (increase of 12 centres) to drive adoption of flow diverters in emerging markets and reduced operator-learning-curve time by 18 %.

Report Coverage of Flow Diverters Market

The report scope for the Flow Diverters Market Research Report encompasses historical data (2018–2023) and forecast period (2024–2030) across multiple geographies and device/application types. Quantitative units include revenue in USD million and market share by region, type and application. The report covers competitive landscape analysis, market segmentation (by type: Pipeline Embolization Device, Silk, Surpass, FRED, p64; by application: aneurysm diameters 2-3 mm, 3-4 mm, 4-5 mm, >5 mm), and regional segmentation (North America, Europe, Asia-Pacific, Middle East & Africa, Latin America).

It also examines growth factors, restraints, opportunities, technological innovations, merger & acquisition activity, regulatory developments and end-user adoption across hospitals and clinics. Data tables include device volumes, average selling prices, installed base estimates, and device replacement/upgrade cycles. The analysis provides B2B-oriented insights for device manufacturers, hospital procurement planners, clinical service line managers and investors seeking to evaluate market entry strategy, competitive benchmarking, and geographic expansion in the Flow Diverters Market.

Flow Diverters Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 414.57 Million in 2026
Market Size Value By	USD 773.79 Million by 2035
Growth Rate	CAGR of 7.18% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Pipeline embolization device (PED) Silk flow diverter (SILK) Surpass flow diverter (SURPASS) FRED flow diverter p64 flow diverter By Application : 2-3 mm 3-4 mm 4-5 mm >5 mm
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample